Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, Status and Forecast 2024-2031

Report ID: 934322 | Published Date: Sep 2024 | No. of Page: 99 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Screening Biomarker
        1.2.3 Diagnosis Biomarker
    1.3 Market by Application
        1.3.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diagnostics
        1.3.3 Drug Discovery
        1.3.4 Personalized Medicine
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Perspective (2016-2027)
    2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Trends by Regions
        2.2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Share by Regions (2016-2021)
        2.2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Regions (2022-2027)
    2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Industry Dynamic
        2.3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Trends
        2.3.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Drivers
        2.3.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Challenges
        2.3.4 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Revenue
        3.1.1 Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Revenue (2016-2021)
        3.1.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Players (2016-2021)
    3.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue
    3.4 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio
        3.4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue in 2020
    3.5 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players Head office and Area Served
    3.6 Key Players Prostate Specific Antigen (PSA) Blood Based Biomarker Product Solution and Service
    3.7 Date of Enter into Prostate Specific Antigen (PSA) Blood Based Biomarker Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Specific Antigen (PSA) Blood Based Biomarker Breakdown Data by Type
    4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Size by Type (2016-2021)
    4.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Type (2022-2027)

5 Prostate Specific Antigen (PSA) Blood Based Biomarker Breakdown Data by Application
    5.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Size by Application (2016-2021)
    5.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
    6.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
        6.2.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
        6.2.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
        6.2.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
    6.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
        6.3.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
        6.3.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
        6.3.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
    6.4 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country
        6.4.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021)
        6.4.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
    7.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
        7.2.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
        7.2.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
        7.2.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
    7.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
        7.3.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
        7.3.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
        7.3.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
    7.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country
        7.4.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021)
        7.4.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
    8.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
        8.2.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
    8.3 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
        8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
    8.4 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region
        8.4.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
    9.2 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
        9.2.1 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
        9.2.2 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
        9.2.3 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
    9.3 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
        9.3.1 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
        9.3.2 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
        9.3.3 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
    9.4 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country
        9.4.1 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021)
        9.4.2 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
    10.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
        10.2.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
    10.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
        10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
    10.4 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country
        10.4.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 ProteoMediX
        11.1.1 ProteoMediX Company Details
        11.1.2 ProteoMediX Business Overview
        11.1.3 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.1.4 ProteoMediX Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.1.5 ProteoMediX Recent Development
    11.2 Cleveland Diagnostics
        11.2.1 Cleveland Diagnostics Company Details
        11.2.2 Cleveland Diagnostics Business Overview
        11.2.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.2.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.2.5 Cleveland Diagnostics Recent Development
    11.3 Randox
        11.3.1 Randox Company Details
        11.3.2 Randox Business Overview
        11.3.3 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.3.4 Randox Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.3.5 Randox Recent Development
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.4.5 Roche Recent Development
    11.5 GENFIT
        11.5.1 GENFIT Company Details
        11.5.2 GENFIT Business Overview
        11.5.3 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.5.4 GENFIT Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.5.5 GENFIT Recent Development
    11.6 Nutech Cancer Biomarkers
        11.6.1 Nutech Cancer Biomarkers Company Details
        11.6.2 Nutech Cancer Biomarkers Business Overview
        11.6.3 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.6.4 Nutech Cancer Biomarkers Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.6.5 Nutech Cancer Biomarkers Recent Development
    11.7 OGT (Sysmex Group)
        11.7.1 OGT (Sysmex Group) Company Details
        11.7.2 OGT (Sysmex Group) Business Overview
        11.7.3 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.7.4 OGT (Sysmex Group) Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.7.5 OGT (Sysmex Group) Recent Development
    11.8 Minomic
        11.8.1 Minomic Company Details
        11.8.2 Minomic Business Overview
        11.8.3 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.8.4 Minomic Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.8.5 Minomic Recent Development
    11.9 Creative Diagnostics
        11.9.1 Creative Diagnostics Company Details
        11.9.2 Creative Diagnostics Business Overview
        11.9.3 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
        11.9.4 Creative Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
        11.9.5 Creative Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Screening Biomarker
    Table 3. Key Players of Diagnosis Biomarker
    Table 4. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions (2016-2021)
    Table 8. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions (2022-2027)
    Table 10. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Trends
    Table 11. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Drivers
    Table 12. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Challenges
    Table 13. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Restraints
    Table 14. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Players (2016-2021)
    Table 16. Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker as of 2020)
    Table 17. Ranking of Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate Specific Antigen (PSA) Blood Based Biomarker Product Solution and Service
    Table 21. Date of Enter into Prostate Specific Antigen (PSA) Blood Based Biomarker Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2016-2021)
    Table 25. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Application (2016-2021)
    Table 29. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. ProteoMediX Company Details
    Table 62. ProteoMediX Business Overview
    Table 63. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product
    Table 64. ProteoMediX Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 65. ProteoMediX Recent Development
    Table 66. Cleveland Diagnostics Company Details
    Table 67. Cleveland Diagnostics Business Overview
    Table 68. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product
    Table 69. Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 70. Cleveland Diagnostics Recent Development
    Table 71. Randox Company Details
    Table 72. Randox Business Overview
    Table 73. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product
    Table 74. Randox Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 75. Randox Recent Development
    Table 76. Roche Company Details
    Table 77. Roche Business Overview
    Table 78. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product
    Table 79. Roche Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 80. Roche Recent Development
    Table 81. GENFIT Company Details
    Table 82. GENFIT Business Overview
    Table 83. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product
    Table 84. GENFIT Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 85. GENFIT Recent Development
    Table 86. Nutech Cancer Biomarkers Company Details
    Table 87. Nutech Cancer Biomarkers Business Overview
    Table 88. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product
    Table 89. Nutech Cancer Biomarkers Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 90. Nutech Cancer Biomarkers Recent Development
    Table 91. OGT (Sysmex Group) Company Details
    Table 92. OGT (Sysmex Group) Business Overview
    Table 93. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product
    Table 94. OGT (Sysmex Group) Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 95. OGT (Sysmex Group) Recent Development
    Table 96. Minomic Company Details
    Table 97. Minomic Business Overview
    Table 98. Minomic Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 99. Minomic Recent Development
    Table 100. Creative Diagnostics Company Details
    Table 101. Creative Diagnostics Business Overview
    Table 102. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product
    Table 103. Creative Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
    Table 104. Creative Diagnostics Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type: 2020 VS 2027
    Figure 2. Screening Biomarker Features
    Figure 3. Diagnosis Biomarker Features
    Figure 4. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application: 2020 VS 2027
    Figure 5. Diagnostics Case Studies
    Figure 6. Drug Discovery Case Studies
    Figure 7. Personalized Medicine Case Studies
    Figure 8. Others Case Studies
    Figure 9. Prostate Specific Antigen (PSA) Blood Based Biomarker Report Years Considered
    Figure 10. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions: 2020 VS 2027
    Figure 13. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions (2022-2027)
    Figure 14. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Players in 2020
    Figure 15. Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue in 2020
    Figure 17. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2016-2021)
    Figure 18. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2022-2027)
    Figure 19. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
    Figure 21. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
    Figure 22. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2016-2027)
    Figure 23. United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
    Figure 27. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
    Figure 28. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2016-2027)
    Figure 29. Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Region (2016-2027)
    Figure 39. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
    Figure 47. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
    Figure 48. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2016-2027)
    Figure 49. Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2016-2027)
    Figure 55. Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. ProteoMediX Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 59. Cleveland Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 60. Randox Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 61. Roche Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 62. GENFIT Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 63. Nutech Cancer Biomarkers Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 64. OGT (Sysmex Group) Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 65. Minomic Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 66. Creative Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ProteoMediX
Cleveland Diagnostics
Randox
Roche
GENFIT
Nutech Cancer Biomarkers
OGT (Sysmex Group)
Minomic
Creative Diagnostics
Frequently Asked Questions
Prostate Specific Antigen (PSA) Blood Based Biomarker report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Specific Antigen (PSA) Blood Based Biomarker report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Specific Antigen (PSA) Blood Based Biomarker report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports